HELI KARELIA: Open Payments
NPI 1275016875 · CAMP HILL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 16 payments from 9 companies in 2025. Trend: 2023 $213 · 2024 $133 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $184 |
| Fresenius USA Marketing, Inc. | 3 | $65 |
| Vifor Pharma, Inc. | 2 | $48 |
| Calliditas Therapeutics US Inc. | 1 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Recor Medical Inc | 1 | $25 |
| AKEBIA THERAPEUTICS INC | 1 | $22 |
| Ardelyx, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: TAVNEOS, VELPHORO, Veltassa, TARPEYO, Vanrafia, Paradise Ultrasound Renal Denervation System, Vafseo, IBSRELA.
Industry payments across PA — which companies pay providers there.
